PL362793A1 - Antagoniści reseptorów histaminowych - Google Patents

Antagoniści reseptorów histaminowych

Info

Publication number
PL362793A1
PL362793A1 PL02362793A PL36279302A PL362793A1 PL 362793 A1 PL362793 A1 PL 362793A1 PL 02362793 A PL02362793 A PL 02362793A PL 36279302 A PL36279302 A PL 36279302A PL 362793 A1 PL362793 A1 PL 362793A1
Authority
PL
Poland
Prior art keywords
reseptor
histamine
antagonists
reseptor antagonists
histamine reseptor
Prior art date
Application number
PL02362793A
Other languages
English (en)
Polish (pl)
Inventor
Stephen Jenkinson
Mark Anthony O'reilly
Michael Andrew Trevethick
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of PL362793A1 publication Critical patent/PL362793A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL02362793A 2001-01-17 2002-01-10 Antagoniści reseptorów histaminowych PL362793A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists
PCT/IB2002/000042 WO2002056871A2 (en) 2001-01-17 2002-01-10 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
PL362793A1 true PL362793A1 (pl) 2004-11-02

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02362793A PL362793A1 (pl) 2001-01-17 2002-01-10 Antagoniści reseptorów histaminowych

Country Status (32)

Country Link
EP (1) EP1353657A1 (is)
JP (1) JP2004517883A (is)
KR (1) KR20030069216A (is)
CN (1) CN1486178A (is)
AP (1) AP2002002401A0 (is)
AR (1) AR032101A1 (is)
BG (1) BG107834A (is)
BR (1) BR0206502A (is)
CA (1) CA2435121A1 (is)
CR (1) CR6983A (is)
CZ (1) CZ20031853A3 (is)
DO (1) DOP2002000325A (is)
EA (1) EA200300537A1 (is)
EC (1) ECSP034692A (is)
EE (1) EE200300335A (is)
GB (1) GB0101223D0 (is)
GT (1) GT200200003A (is)
HU (1) HUP0302767A2 (is)
IL (1) IL156087A0 (is)
IS (1) IS6818A (is)
MA (1) MA26980A1 (is)
MX (1) MXPA03006408A (is)
NO (1) NO20033223D0 (is)
OA (1) OA12440A (is)
PA (1) PA8537101A1 (is)
PL (1) PL362793A1 (is)
PY (1) PY0200477A (is)
SK (1) SK8572003A3 (is)
SV (1) SV2003000849A (is)
TN (1) TNSN02003A1 (is)
WO (1) WO2002056871A2 (is)
ZA (1) ZA200304180B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
EP1545596A4 (en) * 2002-09-06 2005-12-28 Janssen Pharmaceutica Nv USE OF HISTAMINE H4 RECEPTOR MODULATORS FOR THE TREATMENT OF ALLERGIES AND ASTHMA
WO2004066960A2 (en) * 2003-01-28 2004-08-12 Schering Corporation Combination of h1, h3 and h4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
HUE039713T2 (hu) 2012-06-08 2019-02-28 Sensorion H4 receptor inhibitorok tinnitus kezelésére
CN119823227B (zh) * 2025-01-14 2025-07-04 广州迪卡德营养科技有限公司 一种益生菌的制备方法及其在治疗过敏性鼻炎中的用途

Also Published As

Publication number Publication date
IL156087A0 (en) 2003-12-23
SV2003000849A (es) 2003-01-13
AP2002002401A0 (en) 2002-03-31
MXPA03006408A (es) 2003-10-15
BR0206502A (pt) 2003-10-21
CR6983A (es) 2003-11-25
GB0101223D0 (en) 2001-02-28
SK8572003A3 (en) 2004-07-07
NO20033223L (no) 2003-07-16
PY0200477A (es) 2004-06-01
BG107834A (bg) 2004-01-30
PA8537101A1 (es) 2002-08-29
CN1486178A (zh) 2004-03-31
KR20030069216A (ko) 2003-08-25
MA26980A1 (fr) 2004-12-20
EE200300335A (et) 2003-12-15
CA2435121A1 (en) 2002-07-25
ZA200304180B (en) 2004-06-15
TNSN02003A1 (fr) 2005-12-23
DOP2002000325A (es) 2003-01-31
ECSP034692A (es) 2003-08-29
AR032101A1 (es) 2003-10-22
EP1353657A1 (en) 2003-10-22
WO2002056871A2 (en) 2002-07-25
OA12440A (en) 2006-05-22
JP2004517883A (ja) 2004-06-17
IS6818A (is) 2003-05-15
GT200200003A (es) 2002-08-19
NO20033223D0 (no) 2003-07-16
EA200300537A1 (ru) 2004-02-26
HUP0302767A2 (hu) 2003-11-28
CZ20031853A3 (cs) 2004-07-14

Similar Documents

Publication Publication Date Title
NO20032612D0 (no) CXCR3-antagonister
DE60227853D1 (de) Substituierte Pyridinylamine
NO20040733L (no) Integrert borehullsystem
NO20033505L (no) Cannabinoidreseptorligander
ATE439344T1 (de) Muscarin-antagonisten
NO20042742L (no) Pyrimidinforbindelser
DE50206101D1 (de) Induktives bauteil
DE50206892D1 (de) Substituierte imidazotriazinone
NO20014597D0 (no) Fremgangsmåte
SI1425280T1 (sl) Hetero-biciklicni antagonisti crf
DK1373228T3 (da) Substituerede fluoralkoxyphenylsulfonylurinstoffer
DE60222693D1 (de) Nk1-antagonisten
DE60210848D1 (de) Verbinder
DE60201193D1 (de) Induktives Bauteil
DK1372688T3 (da) Somatostatin-antagonister
DE60221366D1 (de) Verbinder
ATE435197T1 (de) Substituierte 4-aminocyclohexanole
DK1467802T3 (da) Nedfiringsanordning
DE50214673D1 (de) Schnittstelle
NO20033223L (no) Histamin-reseptor antagonister
DE50212426D1 (de) Bohrwerkzeug
DE60233695D1 (de) Verbinder
DE50201649D1 (de) Kondensator
DE50108179D1 (de) Verbinder
ATE320254T1 (de) Crf receptor antagonisten

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)